热门资讯> 正文
10 x Genomics赢得针对NanoString的永久禁令
2024-12-23 23:22
- 10X Genomics (NASDAQ:TXG) won a permanent injunction against NanoString Technologies in a patent dispute.
- A permanent injunction will be issued on Jan. 10, U.S. District Judge Matthew F. Kennelly wrote in an opinion on Monday.
- Bruker (BRKR) acquired NanoString’s businesses in May.
- NanoString filed for Chapter 11 bankruptcy protection in February amid ongoing patent litigation with 10xGenomics over its CosMx and GeoMx products.
More on 10x Genomics
- 10x Genomics, Inc. (TXG) Q3 2024 Earnings Call Transcript
- 10x Genomics, Inc. 2024 Q3 - Results - Earnings Call Presentation
- 10x Genomics: Deciphering The Preliminary Q3 Earnings
- 10x Genomics falls 7% on 2024 revenue guidance cut
- 10x Genomics GAAP EPS of -$0.30 beats by $0.02, revenue of $151.64M in-line
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
